Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “SION”

1,496 pharma patents match "SION" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,496
Index total 30,257
Page 36 / 63

Quick answer

This filtered view shows 1,496 pharmaceutical patents matching "SION" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,496 results for “SION” · 30,257 patents in full index Clear search

  1. US 9441227

    Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

    INTEGRATED DNA TECHNOLOGIES, INC. · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted
  2. US 9434931

    Rationally-designed single-chain meganucleases with non-palindromic recognition sequences

    Precision BioSciences, Inc. · Granted Sep 6, 2016 · Expires Sep 1, 2036

    granted
  3. US 9433703

    Neural graft

    HON HAI PRECISION INDUSTRY CO., LTD. · Granted Sep 6, 2016 · Expires Sep 1, 2036

    granted
  4. US 9422347

    Algal produced malarial transmission blocking vaccines

    The Regents of the University of California · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted
  5. US 9422562

    Compositions and methods for inhibiting expression of CD274/PD-L1 gene

    Alnylam Pharmaceuticals, Inc. · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted
  6. US 9415006

    Immunogenic compositions comprising nanoemulsion and hepatitis B virus immunogen and methods of using the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 16, 2016 · Expires Aug 11, 2036

    granted
  7. US 9409956

    Salmonella typhi Ty21a expressing Yersinia pestis F1-V fusion protein and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted
  8. US 9408896

    Vaccination of companion animals to elicit a protective immune response against tick infestations and tick-borne pathogen transmission

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted
  9. US 9404114

    Antisense modulation of GCGR expression

    Ionis Pharmaceuticals, Inc. · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  10. US 9403908

    Method for altering hematopoietic progenitor cell adhesion, differentiation, and migration

    The Regents of the University of California · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  11. US 9404113

    Antisense modulation of PTP1B expression

    Ionis Pharmaceuticals, Inc. · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  12. US 2016213609

    OPHTHALMIC SUSPENSION COMPOSITION

    BAUSCH & LOMB [US] · Granted Jul 28, 2016 · Expires Jul 23, 2036

    granted
  13. US 9399774

    Modulation of transthyretin expression

    Ionis Pharmaceuticals, Inc. · Granted Jul 26, 2016 · Expires Jul 21, 2036

    granted
  14. US 2016206702

    PEGylated Recombinant Human Growth Hormone Compounds

    ASCENDIS PHARMA GROWTH DISORDERS DIVISION AS [DK] · Granted Jul 21, 2016 · Expires Jul 16, 2036

    granted
  15. US 9394545

    Methods and compositions for regulation of transgene expression

    Sangamo Biosciences, Inc. · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted
  16. US 9387249

    Methods of treating hypertension with at least one angiotensin II receptor blocker and chlorthalidone

    Takeda Pharmaceutical Company Limited · Granted Jul 12, 2016 · Expires Jul 7, 2036

    granted
  17. US 9387214

    Method of identifying therapies for pulmonary hypertension

    United Therapeutics Corporation · Granted Jul 12, 2016 · Expires Jul 7, 2036

    granted
  18. US 9376480

    Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted Jun 28, 2016 · Expires Jun 23, 2036

    granted
  19. US 9375424

    Compounds that treat malaria and prevent malaria transmission

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jun 28, 2016 · Expires Jun 23, 2036

    granted
  20. US 9371375

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    PRECISION BIOLOGICS, INC. · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted
  21. US 9370487

    High oil-content emollient aerosol foam compositions

    Precision Dermatology, Inc. · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted
  22. US 9365848

    Modulation of apolipoprotein C-III expression

    Ionis Pharmaceuticals, Inc. · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  23. US 9365849

    Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

    INTEGRATED DNA TECHNOLOGIES, INC. · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  24. US 9353163

    Apelin fusion proteins and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted May 31, 2016 · Expires May 26, 2036

    granted